No. As of September 2026, Biohit Oyj (BIOBV.HE) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Biohit Oyj does not pass Musaffa's business and financial screening criteria.
Biohit Oyj engages in the development, manufacture, and market of diagnostic tests and analysis systems. The company is headquartered in Helsinki, Etela-Suomen and currently employs 46 full-time employees. The firm operates one business segment, named Diagnostics. The Diagnostics segment offers solutions for the early diagnosis and prevention of gastrointestinal diseases. The company provides blood-sample examination based on GastroPanel for the diagnosis of stomach illnesses and associated risks, quick tests for the diagnosis of lactose intolerance and Helicobacter pylori infection in connection with gastroscopy, as well as the ColonView examination for the early detection of fecal occult intestinal bleeding, which indicates a risk of colorectal cancer. The Company’s products are used in hospitals, healthcare centers and research institutions. The company operates primarily in Europe and Asia. Furthermore, the Company is a parent of Biohit Healthcare Ltd, Biohit Healthcare Srl, Oy Finio Ab, and Vantaan Hienomekano Oy, among others.
Biohit Oyj BIOBV.HE
Last Updated: Sep 15, 12:00 AM·OMX
BIOBV.HE Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Biohit Oyj is classified as not halal.